{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06411626",
            "orgStudyIdInfo": {
                "id": "CLNP023C1US01"
            },
            "organization": {
                "fullName": "Novartis",
                "class": "INDUSTRY"
            },
            "briefTitle": "Home Reported Outcomes in PNH",
            "officialTitle": "Home Reported Outcomes in PNH: A Mobile App-Based, Prospective, Observational Program to Evaluate Disease Burden and Treatment Patterns in Paroxysmal Nocturnal Hemoglobinuria in the US",
            "therapeuticArea": [
                "Other"
            ],
            "study": "home-reported-outcomes-in-pnh"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-11",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-05-15",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-05-15",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-05-08",
            "studyFirstSubmitQcDate": "2024-05-08",
            "studyFirstPostDateStruct": {
                "date": "2024-05-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-01",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Novartis Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "descriptionModule": {
            "briefSummary": "The study aims to longitudinally capture the full spectrum of symptoms, treatment utilization, and overall Health-Related Quality of Life (HRQoL) experienced by PNH patients. By primarily utilizing home reported outcomes (HRO) data on symptom burden and treatment usage, supplemented with patient-reported outcome (PRO) measures, the study seeks to establish a new real-world data (RWD) source to understand symptom variability and HRQoL among PNH patients, including those receiving orally administered iptacopan.",
            "detailedDescription": "The study will be prospective and observational, conducted over an initial period of six months per individual from the point of study enrollment. Participants will utilize the Folia mobile app to enroll, consent, and complete all study activities. A hybrid recruitment method of clinic referrals and community referrals will be employed to identify participants, who will be asked to track routine treatment, symptoms, changes in treatment plans, and HRQoL using the Folia Health mobile app. Monthly survey check-ins will be conducted to capture additional data inputs, with the possibility of integrating electronic health record (EHR) and/or claims data."
        },
        "conditionsModule": {
            "conditions": [
                "Paroxysmal Nocturnal Hemoglobinuria"
            ],
            "keywords": [
                "Paroxysmal nocturnal hemoglobinuria",
                "PNH",
                "home reported outcomes",
                "HRO",
                "patient-reported outcome",
                "PRO",
                "real-world data",
                "iptacopan"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 128,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Participants with PNH",
                    "description": "Participants with PNH",
                    "interventionNames": [
                        "Other: PNH-relevant therapies"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "PNH-relevant therapies",
                    "description": "This is an observational study. There is no treatment allocation. The decision to initiate PNH-relevant therapies (such as eculizumab, ravulizumab, pegcetacoplan, iptacopan, and others) will be based solely on clinical judgement.",
                    "armGroupLabels": [
                        "Participants with PNH"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "PNH symptom burden",
                    "description": "Primary endpoint will be measured through longitudinal Home Reported Outcomes (HRO) tracking of self-selected symptoms at enrollment and associated changes in severity against self-reported baselines.",
                    "timeFrame": "Baseline, month 6"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Number of participants by treatment utilization and management of potential flare events",
                    "description": "Treatment utilization and management of potential flare events tracked during the study period",
                    "timeFrame": "Up to 6 months"
                },
                {
                    "measure": "Number of participants by reported treatment use and treatment switching",
                    "description": "HRO-reported treatment use and treatment switching throughout the study duration, triangulated with symptoms reported throughout the study duration",
                    "timeFrame": "Up to 6 months"
                },
                {
                    "measure": "Health-related quality of life (HRQoL)",
                    "description": "HRQoL HRO tracking data:\n\n* Mood \\& behavioral health\n* Productivity\n* Reasons for discontinuing or changing a treatment",
                    "timeFrame": "up to 6 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nStudy participants eligible for inclusion in this study must meet all of the following criteria:\n\n* Aged 18 or older\n* US-based with a proficient understanding of and ability to read the English language\n* Any patient with a diagnosis of PNH, regardless of symptom or treatment history\n\nExclusion Criteria:\n\nStudy participants who do not fit all inclusion criteria listed above are unable to participate in this study. Outside of required inclusion criteria, there are no other exclusion criteria in order to meet the exploratory nature of the primary endpoint.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "99 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Individuals aged 18+ who have been diagnosed with PNH, regardless of symptom or treatment history, and are US-based with a proficient understanding of and ability to read the English language.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Novartis Pharmaceuticals",
                    "role": "CONTACT",
                    "phone": "+41613241111",
                    "email": "novartis.email@novartis.com"
                },
                {
                    "name": "Novartis Pharmaceuticals",
                    "role": "CONTACT"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Novartis Pharmaceuticals",
                    "affiliation": "Novartis Pharmaceuticals",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "East Hanover",
                    "state": "New Jersey",
                    "zip": "07936",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.8201,
                        "lon": -74.36487
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006456",
                    "term": "Hemoglobinuria"
                },
                {
                    "id": "D000006457",
                    "term": "Hemoglobinuria, Paroxysmal"
                }
            ],
            "ancestors": [
                {
                    "id": "D000011507",
                    "term": "Proteinuria"
                },
                {
                    "id": "D000014555",
                    "term": "Urination Disorders"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000020924",
                    "term": "Urological Manifestations"
                },
                {
                    "id": "D000000743",
                    "term": "Anemia, Hemolytic"
                },
                {
                    "id": "D000000740",
                    "term": "Anemia"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000009190",
                    "term": "Myelodysplastic Syndromes"
                },
                {
                    "id": "D000001855",
                    "term": "Bone Marrow Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9542",
                    "name": "Hemoglobinuria",
                    "asFound": "Hemoglobinuria",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9543",
                    "name": "Hemoglobinuria, Paroxysmal",
                    "asFound": "Paroxysmal Nocturnal Hemoglobinuria",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14368",
                    "name": "Proteinuria",
                    "relevance": "LOW"
                },
                {
                    "id": "M17305",
                    "name": "Urination Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22659",
                    "name": "Urological Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M4070",
                    "name": "Anemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M9547",
                    "name": "Hemolysis",
                    "relevance": "LOW"
                },
                {
                    "id": "M4073",
                    "name": "Anemia, Hemolytic",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M14164",
                    "name": "Preleukemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M12145",
                    "name": "Myelodysplastic Syndromes",
                    "relevance": "LOW"
                },
                {
                    "id": "M5134",
                    "name": "Bone Marrow Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4436",
                    "name": "Paroxysmal Nocturnal Hemoglobinuria",
                    "asFound": "Paroxysmal Nocturnal Hemoglobinuria",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3993",
                    "name": "Myelodysplastic Syndromes",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M350841",
                    "name": "Eculizumab",
                    "relevance": "LOW"
                },
                {
                    "id": "M287455",
                    "name": "Ravulizumab",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}